מיטומיצין סי 10 מג
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
MITOMYCIN C (CRYSTALLINE)
Available from:
DEXCEL LTD, ISRAEL
ATC code:
L01DC03
Pharmaceutical form:
אבקה להכנת תמיסה לזריקה
Composition:
MITOMYCIN C (CRYSTALLINE) 10 MG/VIAL
Administration route:
תוך-ורידי, תוך-בטני, לתוך שלפוחית השתן, תוך-עורקי, לתוך קרום הריאה, תוך-שדרתי
Prescription type:
מרשם נדרש
Manufactured by:
KYOWA KIRIN CO. LTD, JAPAN
Therapeutic group:
MITOMYCIN
Therapeutic area:
MITOMYCIN
Therapeutic indications:
Remission of subjective and objective symptoms assocciated with the following diseases: - Chronic lymphocytic leukemia, - chronic myelocytic leukemia, - gastric cancer, - colorectal cancer, - lung cancer, - pancreatic cancer, - liver cancer, - cervix cancer, - cancer of the endometrium, - breast cancer, - head and neck tumor, - bladder tumor.
Authorization date:
2010-08-31
